Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Thrombosis Stories

2013-03-19 11:38:38

BMC Institutes Protocol as a result of findings Researchers from Boston University School of Medicine (BUSM) have found that the use of Inferior Vena Cava (IVC) filters for the prevention and treatment of venous thrombotic events (VTE) may result in poor outcomes due to mechanical filter complications--largely due to low filter retrieval rates and inconsistent use of anticoagulants--and high rates of venous thromboembolism. The study, which was conducted at New England's largest trauma...

2013-03-13 00:20:36

The CHEST Foundation, Through its OneBreath Campaign Unveils kNOw DVT as Part of March DVT Awareness Month NORTHBROOK, Ill., March 13, 2013 /PRNewswire-USNewswire/ -- More than 900,000 Americans each year have a deep vein thrombosis or pulmonary embolism episode which can result in damage to their lungs or other organs and can be fatal. The CHEST Foundation, as part of its OneBreath Initiative, announced the launch of kNOw DVT, a month-long awareness effort that features a series of...

2013-03-08 23:03:40

The Drug Risk Resource Center is the Web´s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Dallas, TX (PRWEB) March 08, 2013 The birth control safety advocates at DrugRisk.com are alerting women who´ve used the vaginal ring contraceptive NuvaRing of updated information added to the site showing the number of injury claims filed over blood clots has risen more than 3% in less than 2 months. “The goal of...

2013-03-08 23:02:41

Individuals and families allegedly injured from the contraceptive device NuvaRing are offered a “No Win - No Free Promise” in cases from potentially harmful side effects suffered while using the contraceptive device. (PRWEB) March 08, 2013 On September 18, 2012, a law firm filed a lawsuit against NuvaRing on behalf of a woman who suffered a deep vein thrombosis while using NuvaRing. The lawsuit was filed in New Jersey Superior Court, Bergen County, and named Merck & Co....

2013-03-07 23:02:21

Dr. Cindy Asbjornsen, founder of the Vein Healthcare Center in Maine, explains deep vein thrombosis (DVT), its symptoms and prevention. South Portland, ME (PRWEB) March 07, 2013 Every year, approximately two million Americans suffer from the effects of blood clots in the deep vein system. According to vein specialist Dr. Cindy Asbjornsen of the Vein Healthcare Center, deep vein thrombosis (DVT), is a blood clot in the deep vein system. The danger of DVT is that the clot could break free...

2013-02-28 16:28:59

- Seeking orphan drug designation in acute limb ischemia (ALI) SAN DIEGO, Feb. 28, 2013 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced its plans to develop ANX-188 in complications of arterial disease, initially as an adjunct to thrombolytics in acute limb ischemia (ALI), a complication of peripheral arterial disease. Peripheral arterial disease affects an estimated 8 to 12 million people in the United States. Arterial disease resulting...

2013-02-18 23:01:42

NuvaRing Side Effects Lawsuit Alleges Merck and Other Defendants Failed to Properly Disclose the Known Safety Hazards Associated with NuvaRing, Including an Increased Risk of Blood Clots Columbus, OH (PRWEB) February 18, 2013 Wright & Schulte LLC, an experienced defective medical device law firm, has filed a NuvaRing lawsuit on behalf of a South Carolina woman who developed two blood clots in her right leg, allegedly caused by NuvaRing. The NuvaRing lawsuit, which names Organon USA,...

2013-02-06 12:26:15

MUNICH, February 6, 2013 /PRNewswire/ -- The registry plans to gather data from more than 4,000 patients with VTE across seven European countries, providing insights into the clinical management of a disease that is a leading cause of morbidity and mortality[1] Daiichi Sankyo Europe GmbH announced the enrolment of the first patient into the PREvention oF thromboembolic events - European Registry in Venous ThromboEmbolism (PREFER in VTE). PREFER in...

2013-01-29 12:27:12

HIGH WYCOMBE, England, January 29, 2013 /PRNewswire/ -- European regulators have approved CE Mark extensions for the transformational geko [http://gekodevices.com/en-us ] device, designed to increase blood circulation for a range of circulatory disorders. Bosses at Firstkind Medical [http://gekodevices.com/en-us/contact/firstkind ], a wholly owned subsidiary of Sky Medical Technology [http://www.skymedtech.com ], say the decision will allow the geko(TM) device to move...

2013-01-24 23:03:13

The DrugRisk Resource Center is the Web´s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Dallas, TX (PRWEB) January 24, 2013 The patient advocates at DrugRisk.com are alerting patients taking the birth control drugs Yaz or Yasmin of new information on the site showing patient claims over alleged blood clots from the drugs has now spread as far as Europe, as settlements continue in the United States....